Erythromycin and alkalinisation of urine in the treatment of urinary-tract infections due to gram-negative bacilli.
D000328:Adult; D000368:Aged; D000468:Alkalies / Q000627:therapeutic use; D001437:Bacteriuria / Q000188:drug therapy; D001639:Bicarbonates / Q000627:therapeutic use; D002908:Chronic Disease; D004917:Erythromycin / Q000009:adverse effects / Q000627:therapeutic use*; D004926:Escherichia coli / Q000302:isolation & purification; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007677:Kidney Function Tests; D007709:Klebsiella / Q000302:isolation & purification; D008111:Liver Function Tests; D008297:Male; D011511:Proteus / Q000302:isolation & purification; D011549:Pseudomonas / Q000302:isolation & purification; D012964:Sodium / Q000627:therapeutic use; D013997:Time Factors; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000209:etiology* / Q000382:microbiology; D014556:Urine / Q000382:microbiology
D000468:Alkalies; D001639:Bicarbonates; D004917:Erythromycin; D012964:Sodium